MRC1 and cancer: Our flow cytometry analysis demonstrated that the conditional medium from Antrocin-treated cells was significantly less capable of generating cancer-associated fibroblasts (CAFs) and M2 tumor-associated macrophages (TAMs), as evidenced by decreased FAP and CD206 expression, respectively (Figure 14E).